| Dr Stephen L Lee, MD,PHD | |
|
1 Medical Center Dr, Dhmc, Department Of Medicine Section Of Neurology, Lebanon, NH 03756-1000 | |
| (603) 650-5104 | |
| (603) 650-6233 |
| Full Name | Dr Stephen L Lee |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 27 Years |
| Location | 1 Medical Center Dr, Lebanon, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154433795 | NPI | - | NPPES |
| 30204670 | Medicaid | NH | |
| 1010895 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 12562 (New Hampshire) | Primary |
| 2084A2900X | Psychiatry & Neurology - Neurocritical Care | 12562 (New Hampshire) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mary Hitchcock Memorial Hospital | Lebanon, NH | Hospital |
| Cheshire Medical Center | Keene, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mary Hitchcock Memorial Hospital | 4486561164 | 964 |
News Archive
Tetraphase Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on next-generation antibiotics, announced today that it is presenting new results from studies that demonstrate the improved potency and pharmacokinetics of several of its newest discovery-stage tetracycline analogs.
A new study appearing in the April issue of The Journal of Bone & Joint Surgery (JBJS), found that most patients who underwent surgery to repair and rebuild an anterior cruciate ligament (ACL) tear, showed significant improvement in physical function at two years, which continued for at least six years following surgery.
Bitplane, an Oxford Instruments Company and world leader in 2-4D image visualization, analysis and interpretation, have announced the launch of Imaris 8.4 in advance of the Society for Neuroscience Annual Meeting in San Diego.
Prostate cancer, notoriously resistant to immunotherapy due to its immunologically cool nature, triggers two pathways to chill an immune attack after one immunotherapy drug fires up the immune system, researchers at The University of Texas MD Anderson Cancer Center report in Nature Medicine.
› Verified 9 days ago
| Entity Name | Mary Hitchcock Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023092053 PECOS PAC ID: 4486561164 Enrollment ID: O20031126000258 |
News Archive
Tetraphase Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on next-generation antibiotics, announced today that it is presenting new results from studies that demonstrate the improved potency and pharmacokinetics of several of its newest discovery-stage tetracycline analogs.
A new study appearing in the April issue of The Journal of Bone & Joint Surgery (JBJS), found that most patients who underwent surgery to repair and rebuild an anterior cruciate ligament (ACL) tear, showed significant improvement in physical function at two years, which continued for at least six years following surgery.
Bitplane, an Oxford Instruments Company and world leader in 2-4D image visualization, analysis and interpretation, have announced the launch of Imaris 8.4 in advance of the Society for Neuroscience Annual Meeting in San Diego.
Prostate cancer, notoriously resistant to immunotherapy due to its immunologically cool nature, triggers two pathways to chill an immune attack after one immunotherapy drug fires up the immune system, researchers at The University of Texas MD Anderson Cancer Center report in Nature Medicine.
› Verified 9 days ago
| Entity Name | Dartmouth-hitchcock Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548210198 PECOS PAC ID: 4183537509 Enrollment ID: O20040809000442 |
News Archive
Tetraphase Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on next-generation antibiotics, announced today that it is presenting new results from studies that demonstrate the improved potency and pharmacokinetics of several of its newest discovery-stage tetracycline analogs.
A new study appearing in the April issue of The Journal of Bone & Joint Surgery (JBJS), found that most patients who underwent surgery to repair and rebuild an anterior cruciate ligament (ACL) tear, showed significant improvement in physical function at two years, which continued for at least six years following surgery.
Bitplane, an Oxford Instruments Company and world leader in 2-4D image visualization, analysis and interpretation, have announced the launch of Imaris 8.4 in advance of the Society for Neuroscience Annual Meeting in San Diego.
Prostate cancer, notoriously resistant to immunotherapy due to its immunologically cool nature, triggers two pathways to chill an immune attack after one immunotherapy drug fires up the immune system, researchers at The University of Texas MD Anderson Cancer Center report in Nature Medicine.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stephen L Lee, MD,PHD 1 Medical Center Dr, Dhmc, Department Of Neurology, Lebanon, NH 03756-1000 Ph: (603) 650-5104 | Dr Stephen L Lee, MD,PHD 1 Medical Center Dr, Dhmc, Department Of Medicine Section Of Neurology, Lebanon, NH 03756-1000 Ph: (603) 650-5104 |
News Archive
Tetraphase Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on next-generation antibiotics, announced today that it is presenting new results from studies that demonstrate the improved potency and pharmacokinetics of several of its newest discovery-stage tetracycline analogs.
A new study appearing in the April issue of The Journal of Bone & Joint Surgery (JBJS), found that most patients who underwent surgery to repair and rebuild an anterior cruciate ligament (ACL) tear, showed significant improvement in physical function at two years, which continued for at least six years following surgery.
Bitplane, an Oxford Instruments Company and world leader in 2-4D image visualization, analysis and interpretation, have announced the launch of Imaris 8.4 in advance of the Society for Neuroscience Annual Meeting in San Diego.
Prostate cancer, notoriously resistant to immunotherapy due to its immunologically cool nature, triggers two pathways to chill an immune attack after one immunotherapy drug fires up the immune system, researchers at The University of Texas MD Anderson Cancer Center report in Nature Medicine.
› Verified 9 days ago
Rebecca Anne Frost, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Drive, Lebanon, NH 03756 Phone: 603-650-6150 | |
Alexander S Kloman, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5000 | |
Dr. Erik J. Kobylarz, MD, PHD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: One Medical Center Drive, Dept. Of Neurology, Dartmouth-hitchcock Medical Center, Lebanon, NH 03756 Phone: 603-653-6118 Fax: 603-650-6233 | |
David D Bae, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Dartmouth Hitchcock - Department Of Psychiatry, Lebanon, NH 03756 Phone: 603-650-6150 | |
Robert Joseph Wendling, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 85 Mechanic Street, Suite 360, Adult & Child Services Of Lebanon, Lebanon, NH 03766 Phone: 603-448-1101 Fax: 603-448-8249 | |
Diane M Roston, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 85 Mechanic St, Suite 360 Recovery Center, Lebanon, NH 03766 Phone: 603-448-5610 Fax: 603-448-8260 | |
Amy M Chan, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: One Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-2967 |